Computational dissection and prediction of cancer immunotherapy response
Checkpoint blockade immunotherapies have transformed the standard of care and outcomes for many cancer types; however. more than 60% of patients still do not experience a durable clinical response from these treatments. To address this problem, the development of novel biomarkers and more effective...
Main Author: | Shi, Alvin |
---|---|
Other Authors: | Kellis, Manolis |
Format: | Thesis |
Published: |
Massachusetts Institute of Technology
2022
|
Online Access: | https://hdl.handle.net/1721.1/139899 |
Similar Items
-
Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse
by: Chao Ma, et al.
Published: (2022-12-01) -
Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection
by: Zhongru Fan, et al.
Published: (2024-01-01) -
Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy
by: Joud Hajjar
Published: (2019-08-01) -
Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data
by: Andrei S. Rodin, et al.
Published: (2021-02-01) -
Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
by: Moonsik Kim, et al.
Published: (2023-08-01)